Canine visceral leishmaniasis: Comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

Veterinary Parasitology

Volumn 135, Issue 2, 2006, Pages 137-146

  Vouldoukis, Ioannis ^a   Rougier, Sandrine ^b   Dugas, Bernard ^a   Pino, Paco ^a   Mazier, Dominique ^a   Woehrlé, Frédérique ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Vetoquinol SA   (France)

Author keywords

Dogs; In vitro; Marbofloxacin; Nitric oxide pathway; Visceral leishmaniasis

Indexed keywords

MARBOFLOXACIN; MEGLUMINE ANTIMONATE; NITRIC OXIDE; STIBOGLUCONATE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DOG; DOSE RESPONSE; MACROPHAGE; MONOCYTE; NONHUMAN; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROBLASTS; FLUOROQUINOLONES; INTERLEUKIN-6; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MACROPHAGES; MEGLUMINE; MICE; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS; PARASITIC SENSITIVITY TESTS; QUINOLONES; TUMOR NECROSIS FACTOR-ALPHA;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 29344475462     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2005.09.003     Document Type: Article

References (56)

1. G.S. Barreca, M.C. Berlinghieri, F. Foti, G. Matera, and A. Foca Microscopic observation of progressive immobilization of Leishmania promastigotes in acridine orange stain J. Clin. Microbiol. 35 1997 1867 1869
2. P. Bianciardi, A. Fasanella, V.F. Manzillo, T. Trotta, A. Aceti, A. Pagano, L. Gradoni, and G. Oliva The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis Parasitol. Res. 93 2004 486 492
3. C. Burri, A.L. Bodley, and T.A. Shapiro Topoisomerases in kinetoplastids Parasitol. Today 12 1996 226 231
4. A. Bryskier Fluoroquinolones Antibiotiques, Agents Antibactériens et Antifongiques 1999 Ellipses Paris pp. 71-73
5. A.K. Chakraborty, and H.K. Majumder Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani Biochem. Biophys. Res. Commun. 152 1988 605 611
6. A.K. Chakraborty, A. Gupta, and H.K. Majumder A type 1 DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani Indian J. Biochem. Biophys. 30 1993 257 263
7. S.J. Cheesman The topoisomerases of protozoan parasites Parasitol. Today 16 2000 277 281
8. S.L. Croft, and J. Hogg Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro Trans. R. Soc. Trop. Med. Hyg. 82 1988 856
9. S.L. Croft, and G.H. Coombs Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 2003 502 508
10. T. Espevik, and J. Nissen-Meyer A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes J. Immunol. Methods 95 1986 99 105
11. R.P. Gladue, G.M. Bright, R.E. Isaacson, and M.F. Newborg In vitro and in vivo uptake of azithromycin (CP-62 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection Antimicrob. Agents Chemother. 33 1989 277 282
12. B.B. Gooding, M.E. Erwin, M.S. Barrett, D.M. Johnson, and R.N. Jones Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates Antimicrob. Agents Chemother. 36 1992 2049 2050
13. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite and [15N]nitrate in biological fluids Anal. Biochem. 126 1982 131 138
14. S.J. Green, M.S. Meltzer, J.B. Hibbs Jr., and C.A. Nacy Activated macrophages destroy intracellular Leishmania major amastigotes by an l-arginine-dependent killing mechanism J. Immunol. 144 1990 278 283
15. S.J. Green, C.A. Nacy, and M.S. Meltzer Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens J. Leukoc. Biol. 50 1991 93 103
16. D.E. Hatzigeorgiou, S. He, J. Sobel, K.H. Grabstein, A. Hafner, and J.L. Ho IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages J. Immunol. 151 1993 3682 3692
17. M. Helle, L. Boeije, and L.A. Aarden Functional discrimination between interleukin 6 and interleukin 1 Eur. J. Immunol. 18 1988 1535 1540
18. M. Helle, J.P. Brakenhoff, E.R. De Groot, and L.A. Aarden Interleukin 6 is involved in interleukin 1-induced activities Eur. J. Immunol. 18 1988 957 959
19. F.Y. Liew, S. Millott, C. Parkinson, R.M. Palmer, and S. Moncada Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine J. Immunol. 144 1990 4794 4797
20. P. Marty, Y. Le Fichoux, F. Pratlong, and M. Gari-Toussaint Human visceral leishmaniasis in Alpes-Maritimes France: epidemiological characteristics for the period 1985-1992 Trans. R. Soc. Trop. Med. Hyg. 88 1994 33 34
21. D. Meunier, J.F. Acar, J.L. Martel, S. Kroemer, and M. Vallé Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries Int. J. Antimicrob. Agents 24 2004 268 278
22. D. Meunier, J.F. Acar, J.L. Martel, S. Kroemer, and M. Vallé A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets Int. J. Antimicrob. Agents 24 2004 592 598
23. N.H. Moskowitz, D.R. Brown, and S.L. Reiner Efficient immunity against Leishmania major in the absence of interleukin-6 Infect. Immun. 65 1997 2448 2450
24. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
25. H.W. Murray Interferon-gamma, the activated macrophage and host defense against microbial challenge Ann. Intern. Med. 108 1988 595 608
26. H.W. Murray, M.J. Oca, A.M. Granger, and R.D. Schreiber Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection experimental visceral leishmaniasis J. Clin. Invest. 83 1989 1253 1257
27. C.A. Nacy, B.J. Nelson, M.S. Meltzer, and S.J. Green Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities Res. Immunol. 142 1991 536 573
28. A.B. Neogy, I. Vouldoukis, J.M. Da Costa, and L. Monjour Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis veterinary group of Lupino Vet. Parasitol. 54 1994 367 373
29. A.K. Nussler, and T.R. Billiar Inflammation, immunoregulation and inducible nitric oxide synthase J. Leukoc. Biol. 54 1993 171 178
30. B.W. Ogunkolade, I. Vouldoukis, D. Frommel, B. Davoust, A. Rhodes-Feuillette, and L. Monjour Immunization of dogs with a Leishmania infantum-derived vaccine Vet. Parasitol. 28 1988 33 41
31. G. Oliva, L. Gradoni, P. Ciaramella, R. De luna, L. Cortese, S. Orsini, R.N. Davidson, and A. Persechino Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum J. Antimicrob. Chemother. 36 1995 1013 1019
32. G. Oliva, L. Gradoni, L. Cortese, S. Orsini, P. Ciaramella, A. Scalone, R. De Luna, and A. Persechino Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis Ann. Trop. Med. Parasitol. 92 1998 165 171
33. M.A. Panaro, A. Acquafredda, S. Lisi, D.D. Lofrumento, V. Mitolo, M. Sisto, A. Fasanella, T. Trotta, F. Bertani, B. Consenti, and O. Brandonisio Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes Comp. Immunol. Microbiol. Infect. Dis. 24 2001 187 195
34. P.G. Pate, J.S. Wolfson, G.L. McHugh, S.C. Pan, and M.N. Swartz Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium Antimicrob. Agents Chemother. 29 1986 426 431
35. H. Pertoft, A. Johnsson, B. Warmegard, and R. Seljelid Separation of human monocytes on density gradients of Percoll J. Immunol. Methods 33 1980 221 229
36. W. Peters, and R. Killick-Kendrick The Leishmaniasis in Biology and Medicine vol. 1 and 2 1987 Academic Press New York pp. 941-954
37. E. Pinelli, R. Killick-Kendrick, J. Wagenaar, W. Bernadina, G. Del Real, and J. Ruitenberg Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum Infect. Immun. 62 1994 229 235
38. E. Pinelli, D. Gebhard, A.M. Mommaas, M. Van Hoeij, J.A. Langermans, E.J. Ruitenberg, and V.P. Rutten Infection of a canine macrophage cell line with Leishmania infantum: determination of nitric oxide production and anti-leishmanial activity Vet. Parasitol. 92 2000 181 189
39. J.F. Prescott, J. Desmond Baggot, and R.D. Walker Fluoroquinolones Antimicrobial Therapy in Veterinary Medicine third ed. 2000 Iowa State University Press/Ames Iowa pp. 315-338
40. W. Raether, H. Seidenath, and J. Hofmann Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo Parasitol. Res. 75 1989 412 413
41. S. Rais, A. Perianin, M. Lenoir, A. Sadak, D. Rivollet, M. Paul, and M. Deniau Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood Antimicrob. Agents Chemother. 44 2000 2406 2410
42. S. Ray, P.K. Sadhukhan, N.B. Mandal, S.B. Mahato, and H.K. Majumder Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines Biochem. Biophys. Res. Commun. 230 1997 171 175
43. C. Riera, J.E. Valladares, M. Gallego, M.J. Aisa, S. Castillejo, R. Fisa, N. Ribas, J. Carrio, J. Alberola, and M. Arboix Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate Vet. Parasitol. 84 1999 33 47
44. G. Riou, S. Douc-Rasy, and A. Kayser Inhibitors of trypanosome topoisomerases Biochem. Soc. Trans. 14 1986 496 499
45. A.C. Rosypal, G.C. Troy, R. Gogal, A.M. Zajac, and D.S. Lindsay Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia J. Eukaryot. Microbiol. 50 2003 691 S693
46. A.C. Rosypal, A.M. Zajac, G.C. Troy, and D.S. Lindsay Infections in immunocompetent and immune deficient mice with promastigotes of a North American isolate of Leishmania infantum Vet. Parasitol. 130 2005 19 27
47. A.C. Rosypal, R.M. Gogal Jr., A.M. Zajac, G.C. Troy, and D.S. Lindsay Cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum Vet. Parasitol. 131 2005 45 51
48. M. Schneider, V. Thomas, B. Boisramé, and J. Deleforge Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration J. Vet. Pharmacol. Ther. 19 1996 56 61
49. M. Sisto, O. Brandonisio, M.A. Panaro, A. Acquafredda, D. Leogrande, A. Fasanella, T. Trotta, L. Fumarola, and V. Mitolo Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages Comp. Immunol. Microbiol. Infect. Dis. 24 2001 247 254
50. R.J. Slappendel Canine leishmaniasis: a review based on 95 cases in The Netherlands Vet. Q. 10 1988 1 16
51. L. Solano-Gallego, P. Morell, M. Arboix, J. Alberola, and L. Ferrer Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology J. Clin. Microbiol. 39 2001 560 563
52. I. Vouldoukis, V. Riveros-Moreno, B. Dugas, F. Ouaaz, P. Becherel, P. Debre, S. Moncada, and M.D. Mossalayi The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen Proc. Natl. Acad. Sci. U.S.A. 92 1995 7804 7808
53. I. Vouldoukis, J.C. Drapier, A.K. Nussler, Y. Tselentis, O.A. Da Silva, M. Gentilini, D.M. Mossalayi, L. Monjour, and B. Dugas Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the l-arginine nitric oxide pathway Antimicrob. Agents Chemother. 40 1996 253 256
54. I. Vouldoukis, P.A. Becherel, V. Riveros-Moreno, M. Arock, O. Da Silva, P. Debre, D. Mazier, and M.D. Mossalayi Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation Eur. J. Immunol. 27 1997 860 865
55. J.C. Wang DNA topoisomerases Annu. Rev. Biochem. 54 1985 665 697
56. WHO, 2000. Fact Sheet No. 116. World Health Organization, Geneva.